发明名称 Immunomodulatory Therapeutic Agents
摘要 A group of peptides has been isolated from the serum of domesticated mammals and then identified through the use of mass spectrometry. These peptides are byproducts of fibrinogen activation and the complement cascade. The peptides of greatest activity are the activated forms of fibrinopeptide A and fibrinopeptide B {activated by the removal of the terminal Arginine), and an immunomodulatory fragment of Complement Component 3. These form of fibrinopeptides A and B have remarkable immunomodulatory ability, enhancing recognition of foreign substances including infectious agents of all types, decreasing the inflammatory response, preventing the deposition of extravascular fibrin, stimulating the resorption of fibrin that has already been deposited, enhancing the body's ability to recognize and eliminate neoplastic cells, decreasing symptoms of allergic reaction including allergic rhinitis and anaphylaxis, decrease the formation and deposit of autoantibody complexes, ameliorate the symptoms of chronic neurologic disease, and decrease the symptoms of chronic pain syndromes.
申请公布号 US2011318375(A1) 申请公布日期 2011.12.29
申请号 US201013203045 申请日期 2010.03.09
申请人 MELLING MITCHELL J.;MELLING WADE M. 发明人 MELLING MITCHELL J.;MELLING WADE M.
分类号 A61K39/00;A61K38/36;A61P37/06;C07K7/06;C07K7/08 主分类号 A61K39/00
代理机构 代理人
主权项
地址